| Literature DB >> 21941678 |
Katherine M McLeod1, C Shanthi Johnson.
Abstract
Osteoporosis is major public health concern affecting millions of older adults worldwide. A systematic review was carried out to identify the most common osteoporosis health beliefs in adult men and women from descriptive and intervention studies. The Osteoporosis Health Belief Scale (OHBS) and Osteoporosis Self-efficacy Scale (OSES) evaluate osteoporosis health beliefs, including perceived susceptibility and seriousness, benefits, barriers, and self-efficacy of calcium and exercise, and health motivation, and their relationship to preventive health behaviours. A comprehensive search of studies that included OHBS and OSES subscale scores as outcomes was performed. Fifty full-text articles for citations were reviewed based on inclusion criteria. Twenty-two articles met the inclusion criteria. Greater perceived seriousness, benefits, self-efficacy, health motivation, and fewer barriers were the most common health-belief subscales in men and women. Few studies were interventions (n = 6) and addressed osteoporosis health beliefs in men (n = 8). Taking health beliefs into consideration when planning and conducting education interventions may be useful in both research and practice for osteoporosis prevention and management; however, more research in this area is needed.Entities:
Year: 2011 PMID: 21941678 PMCID: PMC3175388 DOI: 10.4061/2011/197454
Source DB: PubMed Journal: J Osteoporos ISSN: 2042-0064
Figure 1Flowchart summarizing the search process and study identification.
Mean scores for osteoporosis health belief subscales of descriptive studies.
| Osteoporosis health belief subscale scores (mean and SD) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Author, year | Gender, sample size, and age | Susceptibility | Seriousness | Benefits calcium | Benefits exercise | Barriers calcium | Barriers exercise | Health motivation | Total scoreb |
| Bogoch et al., 2008a | Men and women, | 2.9 (0.9) | 2.7 (0.8) | 3.8 (0.6) | 3.9 (0.6) | 2.1 (0.6) | 2.2 (0.6) | 3.8 (0.6) | NR |
| Carlsson et al., 2004 | Men, | 11.2 | 19.0 | NA | NA | NA | NA | 18.7 | NA |
| Cadarette et al., 2004 | Women, | 17.6 (5.5) | 16.0 (3.4) | 21.2 (3.3) | 23.2 (3.0) | 13.5 (3.3) | 15.3 (3.9) | 24.8 (2.8) | NR |
| Cline and Worely, 2006 | Women, | 14.6 | 14.9 | NA | NA | NA | NA | 15.0 | NA |
| Doheny et al., 2007 | Men, | Men: 14.5 (4.5)* | Men: 17.3 (4.1)* | Men: 22.0 (2.8)* | Men: 24.3 (2.9) | Men: 13.2 (3.6)* | Men: 11.5 (3.9)* | Men: 24.1 (3.3)* | NR |
| Women: 17.1 (5.3) | Women: 18.7 (4.1) | Women: 22.6 (3.5) | Women: 24.4 (3.1) | Women: 12.4 (3.9) | Women: 12.4 (4.5) | Women: 23.4 (3.4) | |||
| Doheny et al., 2010c | Men, | NR | NR | 22.0 (2.8) | 24.4 (2.9) | 13.0 (3.7) | 11.3 (3.9) | 24.2 (3.2) | NR |
| Elliott et al., 2006 | Men, | Men: 17.2 (5.4) | Men: 19.4 (4.3) | Men: 22.3 (3.9) | Men: 21.9 (4.1) | Men: 15.6 (3.9)* | Men: 13.9 (4.9) | Men: 23.7 (4.3) | NR |
| Women: 19.2 (5.3) | Women: 19.2 (4.8) | Women: 23.3 (3.8) | Women: 22.7 (3.9) | Women: 13.3 (4.6) | Women: 14.2 (7.4) | Women: 22.9 (3.8) | |||
| Estok et al., 2007c | Women, | 17.0 (5.6) | 18.7 (4.0) | 22.7 (3.5) | 24.5 (3.2) | 12.3 (3.8) | 12.4 (4.5) | 23.4 (3.4) | NR |
| Johnson et al., 2008 | Men and women, | Men: 8.6 (3.4)*, 10.6 (4.7), 11.4 (4.1) | Men: 13.8 (3.6), 15.4 (3.1), 14.8 (4.1) | NR | NR | NR | NR | Men: 20.2 (4.0), 18.9 (3.9), 19.2 (3.7) | NR |
| Women: 10.9 (4.0)*, 13.6 (5.0), 14.5 (5.3) | Women: 15.6 (3.8), 14.9 (3.5), 15.8 (5.2) | Women: 19.2 (4.4), 19.2 (3.8), 20.2 (3.2) | |||||||
| Lee et al., 2006 | Men, | 16.3 (3.8) | 18.2 (4.3) | 22.3 (2.7) | 22.9 (2.9) | 14.1 (2.9) | 13.6 (2.8) | 23.2 (3.0) | 130.9 (12.9) |
| Sedlak et al., 2000a | Men, | 2.2 (0.6) | NR | NR | NR | NR | NR | NR | NR |
| Swaim et al., 2008a | Women, | 3.1 (0.7) | 3.4 (0.7) | 3.8 (0.6) | 3.9 (0.6) | 2.5 (0.7) | 2.5 (0.7) | 3.9 (0.5) | NR |
| Tan et al., 2009 | Women, | 19.5 (5.0) | 18.5 (5.0) | NR | NR | NR | NR | 21.5 (1.2) | NR |
| Wallace et al., 2002d | Women, | Low CA/EX: 18.3 (4.6) | Low CA/EX: 18.8 (4.2) | Low CA/EX: 24.3 (3.1) | Low CA/EX: 24.7 (3.4) | Low CA/EX: 14.4 (3.6)* | Low CA/EX: 14.8 (4.0)* | Low CA/EX: 20.9 (3.7) | NR |
| High CA/EX: 17.6 (4.6) | High CA/EX: 20.2 (4.2) | High CA/EX: 25.5 (3.2) | High CA/EX: 25.9 (3.2) | High CA/EX: 10.7 (4.1) | High CA/EX: 9.9 (3.4) | High CA/EX: 24.0 (3.6)* | |||
aOn a scale from 1 to 5.
bRange of total score is 42 to 210.
cExperimental study, but reported only descriptive results of entire study population for OHBS.
dLow CA/EX: low calcium intake (<1200 mg/day) and exercise (<90 min/wk), high CA/EX: high calcium intake (≥1200 mg/day) and exercise (≥90 min/wk).
Note: range for each subscale score is 6 to 30 unless otherwise noted. SD: standard deviation, NA: not assessed in the study, NR: not reported.
*Significant difference (P < 0.05) between groups.
Mean scores for osteoporosis self-efficacy subscales of descriptive studies.
| Osteoporosis self-efficacy subscale scores (mean and SD) | ||||
|---|---|---|---|---|
| Author, year | Gender, sample size, and age | Self-efficacy calcium | Self-efficacy exercise | Total scored |
| Bogoch et al., 2008a | Men and women, | 65.9 (26.9) | 81.6 (16.9) | NR |
| Doheny et al., 2007c | Men, | Men: 462.9 (111.6) | Men: 453.4 (128.7)* | NR |
| Women: 460.6 (127.0) | Women: 402.0 (138.0) | |||
| Doheny et al., 2010c | Men, | 77.0 (17.7) | 75.6 (20.6) | NR |
| Elliott et al., 2006a | Men, | Men: 67.4 (27.4) | Men: 73.3 (24.0) | NR |
| Women: 71.9 (26.7) | Women: 63.4 (25.4) | |||
| Estok et al., 2007c | Women, | 459.6 (128.5) | 402.6 (138.6) | NR |
| Gammage et al., 2009b | Men, | Men: 75.4 (19.0) | Men: 84.5 (13.9) | NR |
| Women: 73.5 (18.3) | Women: 77.8 (15.1) | |||
| Sedlak et al., 2000a | Men, | 67.7 (24.6) | 66.9 (25.1) | NR |
| Swaim et al., 2008a | Women, | 69.4 (28.8) | 76.7 (23.8) | NR |
| Wallace et al., 2002a,f | Women, | Low CA/EX: 60.6 (22.2) | Low CA/EX: 48.5 (26.6) | NR |
| High CA/EX: 79.9 (18.6)* | High CA/EX: 83.8 (14.6)* | |||
| Ziccardi et al., 2004c | Men ( | Sophomores: 406.9 | Sophomores: 367.3 | Sophomores: 774.2 |
| Seniors: 438.5 | Seniors: 412.1* | Seniors: 850.5* | ||
a12-item subscale used; score ranges from 0 to 100.
b21-item subscale used; score ranges from 0 to 100.
c12-item subscale used; score ranges from 0 to 600.
dRange of total score for 12-item and 21-item questionnaire is 0 to 1200 and 0 to 2100, respectively.
eExperimental study, but reported only descriptive results of entire study population for OSES.
fLow CA/EX: low calcium intake (<1200 mg/day) and exercise (<90 min/wk), high CA/EX: high calcium intake (≥1200 mg/day) and exercise (≥90 min/wk).
Note: SD: standard deviation, DXA: dual X-ray absorptiometry, NA: not assessed in the study, NR: not reported.
*Significant difference (P < 0.05) between groups.
Mean scores for osteoporosis health belief subscales of intervention studies.
| Osteoporosis health belief subscale scores (mean and SD)a | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Author, year | Gender, sample size (treatment/control), and age | Intervention type | Susceptibility | Seriousness | Benefits calcium | Benefits exercise | Barriers calcium | Barriers exercise | Health motivation | Total scoreb |
| Aree-Ue et al., 2006 | Men and women (97.91%), | 1 group pretest-posttest design; 90 min education session per week (four weeks) + DXA + 1 counseling session. | Pretest: 19.1 (3.0) | Pretest: 21.9 (3.4) | Pretest: 23.7 (4.0) | Pretest: 24.4 (1.8) | Pretest: 15.7 (3.7) | Pretest: 14.8 (4.7) | Pretest: 25.0 (2.9) | Pretest: 145.0 (11.3) |
| after test: 21.8 (5.0)* | after test: 23.0 (5.4) | after test: 25.0 (2.4) | after test: 26.1 (2.5)* | after test: 13.5 (3.8)* | after test: 11.7 (2.5)* | after test: 26.2 (2.2) | after test: 147.6 (12.4) | |||
| Piaseu et al., 2001 | Women; | RCT; 3-hr education program (discussion, demonstration, lecture). | T = 26.1 (3.2)* | T = 27.8 (2.9)* | NR | T = 28.9 (1.3)* | T = 26.9 (2.4)* | T = 27.9 (2.0)* | T = 26.5 (1.9)* | T = 192.1 (9.2)* |
| C = 17.4 (4.1) | C = 22.3 (4.3) | C = 24.6 (3.0) | C = 22.3 (3.9) | C = 23.7 (3.4) | C = 22.0 (3.1) | C = 156.4 (13.2) | ||||
| Sedlak et al., 1998 | Women; | RCT; 3 education sessions (discussion, demonstration, lecture). | T = 19.2 | T = 18.2 | T = 26.6* | T = 28.1 | T = 11.7 | T = 11.0 | T = 25.4 | T = 144.9 (12.2)* |
| C = 12.8 | C = 18.5 | C = 23.8 | C = 25.2 | C = 11.2 | C = 9.1 | C = 23.8 | C = 124.7 (11.0) | |||
| Sedlak et al., 2005 | Women; | RCT; 1 telephone education session + DXA. | NR | NR | NR | NR | T = 13.5* | T = 14.4* | NR | NR |
| Sedlak et al., 2007 | Women; | RCT; DXA screening. | T = 18.1* | NR | NR | NR | T= 11.8 | NR | NR | NR |
| Tung et al., 2006 | Men; | RCT; 2-hr education program (discussion demonstration, lecture). | NR | NR | NR | NR | NR | NR | NR | T = 133.3* |
aRange for each subscale score is 6 to 30.
bRange of total score is 42 to 210.
Note: SD: standard deviation, RCT: randomized controlled trial, DXA: dual X-ray absorptiometry, NA: not assessed in the study, NR: not reported, T: treatment, C: control.
*Significant difference (P < 0.05) between groups.
Mean scores for osteoporosis self-efficacy subscales of intervention studies.
| Osteoporosis self-efficacy subscale scores (mean and SD) | |||||
|---|---|---|---|---|---|
| Author, year | Gender, sample size (treatment/control), and age | Intervention type | Self-efficacy calcium | Self-efficacy exercise | Total score |
| Piaseu et al., 2001c | Women; | RCT; 3-hr education program (demonstration, lecture, discussion). | T = 94.0 (8.6)* | T = 78.3 (9.0)* | NR |
| C = 65.5 (14.2) | C = 57.7 (13.7) | ||||
| Sedlak et al., 1998b | Women; | RCT; 3 education sessions (discussion, demonstration, lecture). | T = 460.2 | T = 425.2 | T = 885.4d (161.2) |
| C = 465.8 | C = 496.5 | C = 962.3 (146.5) | |||
| Tung et al., 2006a | Men, | RCT; 2-hr education program (discussion demonstration, lecture). | NR | NR | T = 731.1d |
a12-item subscale used; score ranges from 0 to 100.
b12-item subscale used; score ranges from 0 to 600.
c21-item subscale used; score ranges from 0 to 100.
dRange of total score for 12-item questionnaire is 0 to 1200.
eRange of total score for 21-item questionnaire is 0 to 2100.
Note: SD: standard deviation, DXA: dual X-ray absorptiometry, NA: not assessed in the study, NR: not reported, T: treatment, C: control.
*Significant difference (P < 0.05) between groups.